Fluctuation of anti-endothelial cell antibody titers in mixed connective tissue disease

Israel Medical Association Journal

Volumn 14, Issue 2, 2012, Pages 84-87

  Lage, Laís V ^a   de Carvalho, Jozélio F ^a   Caleiro, Maria T C ^a   Yoshinari, Natalino H ^a   da Mota, Licia M H ^b   Khamashta, Munther A ^c   Cossermelli, Wilson ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL UNIVERSITÁRIO DE BRASÍLIA   (Brazil)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Anti endothelial cell antibodies; Antibody fluctuation; Endothelial cells; Mixed connective tissue disease (MCTD); Sharp's disease

Indexed keywords

ENDOTHELIAL CELL ANTIBODY; EPITOPE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; HELA CELL; HUMAN; LYMPHOCYTOPENIA; MALE; MIXED CONNECTIVE TISSUE DISEASE; PREDICTION; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULITIS;

ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIXED CONNECTIVE TISSUE DISEASE; SCLERODERMA, SYSTEMIC;

EID: 84857417436     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Sharp GC, Irwin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease - an apparently distinct rheumatic disease associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972; 52: 148-59.
2. Praprotnik S, Blank M, Meroni PL, Rozman B, Eldor A, Shoenfeld Y. Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications. Arthritis Rheum 2001; 44: 1484-94.
3. Ronda N, Leonardi S, Orlandini G, Gatti R, Bellosta S, Bernini F, Borghetti A. Natural anti-endothelial cell antibodies (AECA). J Autoimmun 1999; 13: 121-7.
4. Watanabe H, Kaise S, Takeda I, et al. Anti-endothelial cell antibodies in the sera of patients with mixed connective tissue disease - the clinical significance. Fukushima J Med Sci 1997; 43: 13-28.
5. Bodolay E, Bojan F, Szegedi G, et al. Cytotoxic endothelial cell antibodies in mixed connective tissue disease. Immunol Lett 1989; 20: 163-7.
6. Naniwa T, Sugiura Y, Banno S, Yoshinouchi T, Matsumoto Y, Ueda R. Ribosomal P protein P0 as a candidate for the target antigen of antiendothelial cell antibodies in mixed connective tissue disease. Clin Exp Rheumatol 2007; 25: 593-8.
7. Vegh J, Szodoray P, Kappelmayer J, et al. Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension. Scand J Immunol 2006; 64: 69-76.
8. Bodolay E, Csipo I, Gal I, et al. Anti-endothelial cell antibodies in mixed connective tissue disease: frequency and association with clinical symptoms. Clin Exp Rheumatol 2004; 22: 409-15.
9. Sasaki N, Kurose A, Inoue H, Sawai T. A possible role of anti-endothelial cell antibody in the sera of MCTD patients on pulmonary vascular damage relating to pulmonary hypertension. Ryumachi 2002; 42: 885-94.
10. Kasukawa R. Preliminary diagnostic criteria for classification of mixed connective. In: Kasukawa R, Gordon GC, eds. Mixed Connective Tissue Disease and Anti-nuclear Antibodies. Amsterdam: Excerpta Medica, 1987: 41-7.
11. Lage LV, Caleiro MC, Carvalho JF. Proposed disease activity criteria for mixed connective tissue disease. Lupus (Basingstoke) 2010; 19: 223-4.
12. Rosenbaum J, Pottinger BE, Woo P, et al. Measurement and characterization of circulationg anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol 1988; 72: 450-6.
13. Souza RC, Lage L, Goldesntein-Schainberg C, Macedo AR, Carrasco S, Goncalves CR. Anti-endothelial cell antibodies and central nervous system involvement in Behcet's disease. Clinics 2007; 62: 685-90.
14. Abraham DJ, Krieg T, Distler J, Distler O. Overview of pathogenesis of systemic sclerosis. Rheumatology (Oxford) 2009; 48: iii 3-7.
15. Sgonc R, Gruschwitz MS, Boeck G, Sepp N, Gruber J, Wick G. Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cellmediated cytotoxicity via CD95. Arthritis Rheum 2000; 43: 2550-62.
16. Azeka E, Mendonca LLF, Cossermelli-Messina W, Bonfa E, Khamashta MA, Hughes GRV. Anti-endothelial cell antibodies: marker of ongoing disease acivity in systemic lupus erythematosus. Arthritis Rheum 1999; 42: s149.
17. D'Cruz DP, Houssiau FA, Ramirez G, et al. Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis. Clin Exp Immunol 1991; 85: 254-61.
18. Yazici ZA, Raschi E, Patel A, et al. Human monoclonal anti-endothelial cell IgG-derived from a systemic lupus erythematosus patient binds and activates human endothelium in vitro. Int Immunol 2001; 13: 349-57.
19. Hasselaar P, Derden RHWM, Blokzijl L, De Groot PG. Crossreactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets. Thromb Haemost 1990; 63: 169-73.
20. Meroni PL, Khamashta MA, Youinou P, Shoenfeld Y. Mosaic of antiendothelial antibodies: review of the first international workshop on AEA. Clinical and pathological significance. Lupus 1995; 4: 95-9.
21. Damianovich M, Gilburd B, George J, et al. Pathogenic role of anti-endothelial cell antibodies in vasculitis. J Immunol 1996; 156: 4946-51.
22. Kollmeier A, Kreditor M, George J, Levy Y, Shoenfeld Y. Functional properties of antiendothelial cell antibodies. Clin Rev Allergy Immunol 1998; 16: 297-311.
23. Soltesz P, Kerekes G, Der H, et al. Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment. Autoimmun Rev 2011; 10: 416-25.
24. Tomasoni L, Sitia S, Borghi C, et al. Effects of treatment strategy on endothelial function. Autoimmun Rev 2010; 9: 840-4.
25. Domiciano DS, Carvalho JF, Shoenfeld Y. Pathogenic role of anti-endothelial cell antibodies in autoimmune rheumatic diseases. Lupus 2009; 18: 1233-8.